medigraphic.com
SPANISH

Revista del Centro Dermatológico Pascua

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Authors instructions        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 3

Rev Cent Dermatol Pascua 2011; 20 (3)

Genital fixed pigmented erythema. A 69-case study

Muñoz EVF, Valenzuela PGA
Full text How to cite this article

Language: Spanish
References: 27
Page: 91-99
PDF size: 127.86 Kb.


Key words:

Fixed drug eruption, drug reaction.

ABSTRACT

Fixed drug eruption is a farmacodermia characterized by the recurrence of lesions in the same sites after reexposure to the causative agent. Objectives: Determine clinical characteristics of patients with genital fixed drug eruption, and identify associated drugs with this pathology. Patients and methods: A descriptive, observational, retrospective and transversal study of 69 cases of genital fixed drug eruption studied in Department of Dermatology and Mycology of the CIDOCS-UAS of Culiacán, Sinaloa, México, from 1 January 1999 to 31 August 2010. Results: 86.95% were male, between 21 to 40 years-old (73.91%), predominated erythematous spots with blisters in 27.53% of men and 8.69% in women; the most frequent site in men was the glans 52.81%, and in women the introitus vaginal 7.87%, the evolution was ‹ 1 month in 50.72%. The causative agent more common in men was trimethoprim sulfamethoxazole, and in women alprazolam, ibuprofen and trimethoprim-sulfamethoxazole. Conclusion: We identified 69 cases of genital fixed drug eruption, wich is more common in men related to 23 causative agents.


REFERENCES

  1. Saúl A. Lecciones de dermatología. 15ª Ed. Méndez editores, 2008: 385-465.

  2. Muñoz V, Rubio M, Douriet F, Domínguez G. Eritema pigmentado fijo atípico por diaminodifenilsulfona. Bol Med UAS 2006; 2: 36-39.

  3. Ozkaya BE, Bayazit H, Ozarmagan G. Drug related clinical pattern in fixed drug eruption. Eur J Dermatol 2000; 10: 288-91.

  4. Nussinovitch M, Prais D, Ben-Amitai D, Amir J, Volovitz B. Fixed drug eruption in the genital area in 15 boys. Pediatric Dermatology 2002; 3: 216-219.

  5. Buechner SA. Common skin disorders of the penis. BJU International 2002; 90: 498-506.

  6. Gendernalik S, Galeckas K. Fixed drug eruptions: a case report and review of the literature. Cutis 2009; 84: 215-219.

  7. Oyama N, Kaneko F. Solitary fixed drug eruption caused by finasteride. J Am Acad Dermatol 2009; 60: 168-169.

  8. Topliss D, Gold M, Kotsirilos V, Lander C, McNeil J, Pillans P et al. Fixed drug eruption. Aust Adv Drug Reactions Bull 2009; 28: 14.

  9. Berrón A. Eritema pigmentado fijo. Revisión de la literatura. Rev Cent Dermatol Pascua 1995; 4: 121-126.

  10. Lázaro P, Avilés JA. Exantema fijo medicamentoso. JANO 2004; LXVII: 1092.

  11. Sehgal VN, Srivastava G. Fixed drug eruption (FDE): changing scenario of incriminating drugs. Int J Dermatol 2006; 45: 897-908.

  12. Butler D. Fixed drug eruptions. eMedicine Specialties [on line] 2007. Disponible en: http://emedicine.medscape.com/article/1336702-overview

  13. Wain EM, Neill S. Fixed drug eruption of the vulva secondary to fluconazole. Clin Exp Dermatol 2008; 33: 784-785.

  14. Rasi A, Khatami A. Unilateral non-pigmenting fixed drug eruption associated with cotrimoxazole. Dermatol Online J 2006; 12: 12.

  15. Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998; 37: 833-838.

  16. Gupta R. Drugs causing fixed drug eruptions: confirmed by provocation test. Indian J Dermatol Venereol Leprol 2003; 60: 120-121.

  17. Pandhi RK, Kumar AS, Satish DA, Bhutani LK. Fixed drug eruptions on male genitalia: clinical and etiologic study. Sex Transm Dis 1984; 11: 164-166.

  18. Sehgal VH, Gangwani OP. Genital fixed drug eruptions. Genitourin Med 1986; 62: 56-58.

  19. Fischer G. Vulvar fixed drug eruption: a report of 13 cases. J Reprod Med 2007; 52: 81-86.

  20. Csonka GW, Rosedale N, Walkden L. Balanitis due to fixed drug eruption associated with tetracycline therapy. Brit J Vener Dis 1971; 47: 42-44.

  21. Ozkaya-Bayazit E. Specific site involvement in fixed drug eruption. J Am Acad Dermatol 2003; 49: 1003-1007.

  22. Gruber F, Stasic A, Lenkovic M, Brajac I. Poscoital fixed drug eruption in a man sensitive to trimethoprim-sulphamethoxazole. Clin Exp Dermatol 1997; 22: 144-145.

  23. Brahimi N, Routier E, Raison-Peyron N, Tronquoy AF, Pouget-Jasson C, Amarger S et al. A three-year-analysis of fixed drug eruptions in hospital settings in France. Eur J Dermatol 2010; 20: 461-464.

  24. Lawrence M, Nelson MD. Fixed drug eruptions: a report of two cases, one caused by niacin, the other by cocaine. Calif Med 1955; 82: 127-128.

  25. Lugo O, Cancela R. Patología cutánea del pene. Rev Cent Dermatol Pascua 1999; 8: 133-142.

  26. Sacks S. Genital ulcers: their diagnosis and management. Can Fam Physician 1987; 33: 1801-1809.

  27. Fernández-Durán D, Rodríguez-Vidigal FF. Protocolo diagnóstico y tratamiento empírico de las lesiones ulceradas en el área genital. Medicine 2006; 9: 3601-3605.




2020     |     www.medigraphic.com

Mi perfil

CÓMO CITAR (Vancouver)

Rev Cent Dermatol Pascua. 2011;20